Enhancers: The abundance and function of regulatory sequences beyond promoters  by Bulger, Michael & Groudine, Mark
Developmental Biology 339 (2010) 250–257
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyReview
Enhancers: The abundance and function of regulatory sequences beyond promoters
Michael Bulger a,⁎, Mark Groudine b
a Center for Pediatric Biomedical Research, Department of Pediatrics, University of Rochester, Rochester, NY, USA
b Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Radiation Oncology, University of Washington, Seattle, WA, USA⁎ Corresponding author.
E-mail address: Michael_Bulger@urmc.rochester.edu
0012-1606/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.ydbio.2009.11.035a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 16 July 2009
Revised 24 November 2009
Accepted 30 November 2009
Available online 16 December 2009
Keywords:
Enhancers
Locus control regions
Insulators
Chromatin
Gene Expression
Transcription
Gene Regulation
Nuclear OrganizationTranscriptional control in mammals and Drosophila is often mediated by regulatory sequences located far
from gene promoters. Different classes of such elements – particularly enhancers, but also locus control
regions and insulators – have been deﬁned by speciﬁc functional assays, although it is not always clear how
these assays relate to the function of these elements within their native loci. Recent advances in genomics
suggest, however, that such elements are highly abundant within the genome and may represent the
primary mechanism by which cell- and developmental-speciﬁc gene expression is accomplished. In this
review, we discuss the functional parameters of enhancers as deﬁned by speciﬁc assays, along with the
frequency with which they occur in the genome. In addition, we examine the available evidence for the
mechanism by which such elements communicate or interact with the promoters they regulate.
© 2010 Elsevier Inc. All rights reserved.Introduction
Transcriptional regulation is accomplished via the association of
trans-acting factors with regulatory DNA sequences. As might be
expected, DNA sequences located close to gene promoters are
universally involved in this regulation, and in fact in many
organisms, including bacteria and unicellular eukaryotes, the vast
majority of regulatory phenomena are limited to the few hundred
base pairs upstream of the transcription start site. A wealth of studies
of gene regulation in vertebrates and in Drosophila, however, indicate
that at least in these organisms additional classes of regulatory
elements – enhancers, locus control regions (LCRs) and insulators –
can be located far from the transcription start site, and that at
complex loci multiple elements that are arrayed over large regions
can collaborate in regulation of expression of individual genes or
gene clusters.
The existence of regulatory sequences located far from the
promoters they regulate poses a number of questions, most notably
how such elements bridge the distance to their cognate promoters to
mediate whatever regulatory effects they may have, or alternatively
what regulatory functions can be accomplished over such distances.
Ongoing interest in these questions has led to the development of
novel technologies to probe for interactions between distal sequence
elements, which in turn have placed enhancer and LCR function(M. Bulger).
ll rights reserved.squarely at the nexus of regulation of RNA polymerase II transcription,
modulation of chromatin structure and organization of the genome
within the nucleus.
Activities of distal regulatory elements: enhancers, LCRs and
boundary elements
Although studies of the characteristics and function of distal
regulatory sequences within their endogenous loci are becoming
more frequent, most often such elements have been deﬁned in
artiﬁcial gain-of-function assays, which have revealed distinct classes
of regulatory sequences (Maston et al., 2006). Enhancers, for example,
are deﬁned by their activity in assays involving the transient
transfection of reporter genes into cultured cells. Such elements are
capable of activating transcription regardless of how far they are
located from a promoter (within the spatial limitations of the plasmid
DNA constructs used for the assay) or their position relative to it – i.e.,
upstream or downstream.
Another class of regulatory sequences is identiﬁed by the
establishment of consistent levels of gene expression upon stable
integration into the genome of either cultured cells or transgenic
mice. Transgenes in general are subject to position effects, in which
expression levels are highly dependent upon the genomic site into
which a transgene is inserted. Gene promoters by themselves are
capable of driving expression in only a small proportion of integration
sites. Some sequence elements, however, are capable of conferring
high-level gene expression to linked promoters in a position-
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transcription at the majority of genomic locations, and is the
functional deﬁnition of a locus control region (LCR).
Sequence elements that exhibit enhancer or LCR activity, as
deﬁned by these speciﬁc functional assays, have been derived from
multiple gene loci and thus appear to represent a general phenom-
enon (Li et al., 1999; Maston et al., 2006). The distinct functional
deﬁnitions of enhancers and LCRs, however, raise the question of how
these elements differ intrinsically. At least some LCRs appear to
subsume the function of enhancers. For example, the LCR within the
human β-globin locus harbors at least one element, 5′ DNaseI-
hypersensitive site 2 (5′HS2) that acts as an enhancer in transient
assays (Hardison et al., 1997). The immediate question would appear
to be one of quantity vs. quality: does an LCR consist of the same
activity as an enhancer, only more powerful, or does it possess a
different class of activity?
Evidence exists to support both possibilities. HS2 of the human β-
globin LCR can confer position-independent expression to transgenes
in mice, but only when 5′HS2-containing transgenes are integrated
with copy numbers greater than 3–4 (Ellis et al., 1993). One
interpretation of this behavior is that a sufﬁcient number of HS2
enhancer elements can add up to an LCR, although this has never been
investigated systematically.
On the other hand, the β-globin LCR also harbors at least two
elements – 5′HSs 3 and 4 – that generally exhibit little activity in
transient assays, but activate transcription of linked genes when
stably integrated in the genome (Hardison et al., 1997), and
regulatory regions have been derived from other loci that behave
similarly. This activity suggests that transient and stable assays of
gene expression can reveal different mechanisms of gene activa-
tion, and that LCRs can function in ways that are distinct from
enhancers.
Additional indications of a fundamental difference between LCR
and enhancer activity are provided by studies of the immunoglobulin
enhancer Eμ (Forrester et al., 1994), the thymic enhancer of the
adenosine deaminase gene (Aronow et al., 1995) and the human CD2
LCR (Festenstein et al. 1996). In each case, a core sequence possesses
enhancer activity in transient assays but does not function as an LCR in
transgenic assays. LCR activity is observed when additional ﬂanking
elements, which possess no measurable activity on their own, are
included with the core enhancer. Such activity has been correlated
with the propagation of a more accessible chromatin structure from
the LCR to more distal sequences.
Another class of promoter-distal regulatory element consists of
insulators (Gaszner and Felsenfeld, 2006). The term “insulator” in turn
encompasses two distinct subclasses of activity. First, “barrier”
elements are deﬁned by their ability to insulate stably transfected
transgenes from position effects. This is superﬁcially similar to the
activity that deﬁnes LCRs, but is different in mechanism: barrier
elements are only effective when they ﬂank the transgene to either
side, while an LCR functions in any orientation with respect to a
transgene. The most common interpretation of this behavior is that a
barrier serves to block the encroachment of repressive chromatin
structure from a given integration site, while an LCR actively functions
to establish a chromatin structure that is more conducive to gene
expression. The most well-characterized barrier element to date is 5′
HS4 of the chicken β-globin locus; a speciﬁc sequence within this
element is bound by USF transcription factors and has been shown in
multiple studies to insulate transgenes from position effects (Huang
et al., 2007).
The second subclass of insulator consists of “enhancer-blocking”
elements, which are deﬁned by their ability to block the function of an
enhancer on a linked promoter, but only when located between the
enhancer and promoter. They do not appear to silence enhancers or
promoters; an enhancer that is blocked from activating a promoter to
one side of it by an enhancer-blocking element is still able to activate apromoter located on the other side (Dorsett, 1999). Prominent
examples of such enhancer-blocking elements include (again) 5′HS4
of the chicken β-globin locus, speciﬁcally a binding site for the
transcription factor CTCF (Bell et al., 1999). InDrosophila, binding sites
for the suppressor of Hairy wing [su(Hw)] factor can mediate the
same effect (Gdula et al., 1996).
It is not clear that sequences deﬁned as enhancers, LCRs or
enhancer-blocking elements in artiﬁcial assays necessarily mediate
such functions within the loci from which they are derived.
Endogenous regulatory elements normally have no need to ensure
gene expression frommore than one location within the genome, and
so it is not obvious how the ability of an LCR to overcome transgene
position effects relates to its function at its native location. For
example, deletion of the immunoglobulin enhancer Eμ conforms to
the model that transgenic studies would predict, in that expression
from the mutant locus is variegated, involving complete silencing of
the locus in the majority of cells (Ronai et al., 1999). Deletion of the
murine β-globin LCR, however, while leading to a severe reduction in
β-globin expression levels in all cells, fails to affect any measurable
feature of chromatin structure within the locus. Themajor function for
this element, as revealed by the deletion, appears to be in
transcriptional elongation (Bender et al., 2000; Schubeler et al.,
2001; Sawado et al., 2003).
Discrepancies like this could arise from the existence of additional,
redundant activities at endogenous loci. Such studies do suggest,
however, that the artiﬁcial assays used to characterize the function of
distal regulatory elements should be interpreted with caution with
respect to the role of such sequences within their native loci.
Distal regulatory elements in mammalian genomes
The development and generalized use of high-throughput and/or
genome-wide methodologies for examining transcription factor
binding, core histonemodiﬁcations and RNA polymerase II association
has drastically altered the perception of how regulatory sequences are
distributed in mammalian genomes. In contrast to the budding yeast
Saccharomyces cerevisiae, for example, the human genome is only
sparsely populated with protein-coding genes, and even when
growing awareness of noncoding genes, such as small RNAs, is
considered, it is readily apparent that the largest proportion of the
genome consists of intergenic or intragenic (intronic) sequences for
which a speciﬁc function is not obvious. Prior studies of selected gene
loci have identiﬁed distal regulatory sequences such as enhancers and
LCRs within these regions, but the gain-of-function assays used to
characterize these elements have only served to delineate one or a
few such elements for each locus, leaving the majority of noncoding
DNA with no known function.
More recently, however, distal regulatory elements have been
distinguished from gene promoters by a signature of histone
modiﬁcations and trans-acting factor binding identiﬁed via genome-
wide microarray and high-throughput sequencing (chIP-seq) (The
ENCODE Project Consortium, 2007; Koch et al., 2007; Heintzman et al.,
2007; Heintzman et al., 2009; Visel et al., 2009). Features of this
signature include monomethylation of histone H3 lysine 4 (H3K4)
and association of speciﬁc factors, such as the histone acetyltransfer-
ase and transcriptional coactivator p300. Levels of H3K4 monomethy-
lation in particular peak at enhancers and not at transcription start
sites. Conversely, H3K4 trimethylation appears to occur at promoters
but not at enhancers. In addition, there is a strong correlation between
these regulatory elements and the locations of DNaseI-hypersensitive
sites (DNaseI HSs), which are generally thought to mark regions
where local chromatin structure is disrupted by transcription factor
binding (Xi et al., 2007).
Both H3K4 monomethylation and p300 binding have proven to
be predictive for enhancer activity of genomic elements in
functional assays (The ENCODE Project Consortium, 2007; Heintzman
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example, any sequence that is bound by p300 might be expected to
exhibit enhancer activity in a transient transfection assay when linked
to a reporter gene, but this doesn't necessarily indicate that such a
sequence actually functions as an enhancer at its native location.
Still, current high-throughput studies are intriguing in several
ways. First, they have revealed an unexpected abundance of putative
enhancer sequences. A genome-wide study utilizing only two cell
lines identiﬁed 55,000 sequences exhibiting the “chromatin signa-
ture” indicative of enhancers (Heintzman et al., 2009), which is
signiﬁcantly larger than the number of genes expressed in these lines.
The signature at most of these sequences was speciﬁc to one or the
other cell type as well, and given the variety of cell types present in
mammals, the authors extrapolated this ﬁgure to estimate that the
human genome harbors 105–106 such elements in total. This would
represent an average across the genome of one such element every
3000–30,000 bp, with signiﬁcantly higher densities in “gene-rich”
regions. A pilot survey of 1% of the human genome by the ENCODE
project revealed a similar frequency of occurrence of monomethyl
H3K4 not associated with gene promoters (The ENCODE Project
Consortium, 2007; Koch et al., 2007).
Second, comparisons of patterns of histone modiﬁcation and
transcription factor association between putative enhancers and
known transcription start sites have suggested that the greatest
differences between cell types lie in the distal enhancers, not the
promoters (Heintzman et al., 2009). Similarly, mapping of DNaseI HSs
across six different cell lines showed that the majority, which were
common among all of the lines, were associated with promoters or
putative insulator elements, while the remaining cell type-speciﬁc
HSs were highly enriched for enhancer elements (Xi et al., 2007). The
implication is that development and differentiation of disparate cell
types is accomplished for themost part via the differential activities of
distal regulatory elements like enhancers.
Since the initial discovery of enhancers, it has been known that
they are most often the dominant element in conferring tissue
speciﬁcity to a linked gene. A hallmark of most enhancers is their
ability to activate transcription from any linked promoter in reporter
gene constructs, even if promoter and enhancer originate from gene
loci with completely different expression patterns in vivo. Although
there are exceptions to the general principle, expression of the
reporter gene follows the pattern governed by the enhancer, not the
promoter. This ability, in fact, has been used to identify enhancers (or,
more correctly, regions of the genome) that drive speciﬁc expression
patterns, via the “enhancer trap” – a transgene under the control of a
weak promoter will only be expressed if it integrates into a genomic
location that is under the inﬂuence of an enhancer that can activate
the promoter. The importance of enhancers in determining patterns of
eukaryotic gene expression is also illustrated by known examples of
genes expressed in different tissues or locations in an organism, which
in turn are regulated by multiple enhancers, each of which speciﬁes
part of the expression pattern.
On the other hand, the ﬁnding that differences in histone
modiﬁcation patterns and transcription factor binding between cell
types localizes most often to enhancers and not promoters would
seem to conﬂict with the known prevalence of genes with multiple
promoters. Genome-wide analyses have shown that more than 50%Fig. 1. Potential mechanisms underlying distal enhancer-promoter colocalization. (A) The
enhancer (ENH) and other proteins bound to the promoter (PRO) directly interact with each
II (as shown), stimulation of RNA polymerase II elongation (as demonstrated for the β-glob
available evidence, we have depicted the majority of intervening sequence between the enh
structure is not well understood and so compaction may be more extensive than this. (B) E
“factories.” In this model, factors bound to both enhancer and promoter independently recr
however, this amounts to enhancer and promoter colocalizing to the same “factory.” The g
transcription factories. (C) Enhancer and promoter interactions with speciﬁc transcription
factories. Such speciﬁc association is presumably mediated by some common factor or comp
respectively), and would be expected to underlie speciﬁc interchromosomal interactions.of human genes (Kimura et al., 2006; Carninci et al., 2006), and ∼14%
of genes in Drosophila (Zhu and Halfon, 2009), are associated with
multiple transcription start sites, and the literature is abundant with
examples of genes that are expressed in different cell types via
different promoters. It would appear, however, that expression from
these alternate promoters is under the control of multiple, alternate
enhancers, and that in the majority of cases tissue-, developmental-
and/or differentiation stage-speciﬁc transcription is under the
control of distal regulatory elements that are dominant over the
promoter(s).
Third, genome-wide and otherwise high-throughput studies of
putative enhancers have unexpectedly revealed that a substantial
proportion of such elements are not evolutionarily constrained (The
ENCODE Project Consortium, 2007; Margulies et al., 2007). In the
ENCODE pilot survey, roughly half of the sequences determined to
have activity in functional assays did not appear to be subject to
evolutionary constraint based on cross-species sequence compari-
sons. Previously, sequence conservation in regions of the genome not
associated with gene-coding exons has been used to support other
lines of evidence for function of distal regulatory elements, and in fact
such conservation has been used as a predictive tool to identify
potential regulatory regions, a technique termed “phylogenetic
footprinting” (Hardison, 2000). The results of the ENCODE analysis
indicate either that many distal regulatory elements cannot be
identiﬁed on the basis of DNA sequence conservation, or that the
conserved sequences within these elements are so small as to escape
detection by commonly used computer-based algorithms.
A study of the embryonic enhancers of the even-skipped gene in
Drosophila as compared to scavenger ﬂies (Sepsidae) illustrates how
this might occur (Hare et al., 2008). Although the DNA sequences of
the enhancer regions in either species are highly divergent, they
function to accomplish embryonic patterns of even-skipped expression
that are nearly identical. Conservation of small sequence motifs was
also excluded. Thus, highly speciﬁc function of a set of distal
regulatory elements can be conserved even when DNA sequence is
not. Speculation for how this can occur has focused on the possibility
of compensatory mutations – that is, pairs of mutations that together
are not as deleterious as would be expected for single mutations
(Veitia, 2008). In addition, an enhancer could conceivably recruit the
same activating complex, but interact with different components of it.
Over time, the entire sequence of an enhancer can be transformed
while maintaining function.
Some caution in generalization of these studies is warranted, in that
thus far they have exclusively utilized transformed cell lines, and so it is
not yet clear that primary tissues follow the same pattern. Still, these
genome-wide studies of histonemodiﬁcationpatterns and transcription
factor binding have provided a strong suggestion that in at least some
metazoans the genome is rife with promoter-distal sequences that
represent the dominant regulatory elements in gene expression.
Interactions of distal regulatory elements and nuclear
organization
Since the discovery of enhancers, one of the most important
questions related to their function has been how they regulate
promoters located far from them along a linear chromosome. The“traditional” view of enhancer-promoter interactions, in which proteins bound to the
other to facilitate transcriptional activation, whether by recruitment of RNA polymerase
in LCR), or another mechanism. Blue circles represent nucleosomes; based on the best
ancer and promoter as condensed to the 30 nm ﬁber, although higher-order chromatin
nhancer-promoter colocalization by association with RNA polymerase II transcription
uit RNA polymerase II; in a nuclear environment consisting of transcription “factories,”
reen circles represent as-yet undeﬁned, non-Pol II proteins presumed to be present in
factories. In this model, different genes associate with different kinds of transcription
lex recruited to both the enhancer and the promoter (denoted by violet or green circles,
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association of an enhancer with a promoter, although several
mechanisms have been put forward to explain how such juxtaposi-
tions might take place. The development of the Chromosomal
Conformation Capture (3C) technique and its variants has provided
the means to map interactions between distal sequences within thenucleus, including those that may occur between enhancers and
promoters (Dekker et al., 2002). In this technique, cells are cross-
linked with formaldehyde and subjected to digestion with restriction
endonucleases, then incubated with DNA ligase. Genomic restriction
fragments that colocalize in the nucleus are then able to ligate with
each other, regardless of their positions on the linear genome, and at
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regions of the nucleus. The technique was originally applied to verify
the colocalization of telomeres in nuclei of the budding yeast S.
cerevisiae (Dekker et al., 2002), but was quickly extended to reveal
interactions between distal regulatory sequences and promoters in
mammalian cells, initially at the β-globin locus (Tolhuis et al., 2002),
and since then at a large and growing number of gene loci (Miele and
Dekker, 2008).
The 3C assay has been used to demonstrate that within the murine
β-globin locus, sequences dispersed throughout a region of 100–
200 kb appear to colocalize within the nucleus in erythroid cells.
These include the LCR, the active genes within the cluster, a sequence
located ∼20 kb downstream of the locus (3′HS1), and additional
sequences that are located further upstream of the LCR (−60 HS), to
which erythroid-speciﬁc HSs have beenmapped (Tolhuis et al., 2002).
This agglomeration of elements is termed the “active chromatin hub”
(ACH), and the association of the β-globin gene promoters with the
ACH has been precisely correlated with their activity. Thus, in
erythroid cells that lack transcription factors crucial for β-globin
gene expression, such as GATA-1 and EKLF, the β-globin genes do not
appear to colocalize with the LCR or other sequences (Drissen et al.,
2004; Vakoc et al., 2005). Furthermore, in erythroid progenitors that
do not yet express the β-globin genes, a subset of the elements that
make up the ACH – 3′HS1, −60 HS, and HS5 of the LCR – and which
are bound by CTCF still colocalize. The presumed structure that results
has been termed a “pre-ACH” or simply a “chromatin hub” (CH), and it
has been speculated that the formation of the ACH occurs on this pre-
formed core (Palstra et al., 2003).
3C has also been used to elucidate association or colocalization of
distal sequences within the Th2 cytokine locus in T-lymphocytes
(Spilianakis and Flavell, 2004). In addition to a complex pattern of
colocalization of various sequences within this region, however,
selected promoters and other elements appear to colocalize with
other elements within the Ifnγ locus, located on another chromo-
some (Spilianakis et al., 2005). This apparent interchromosomal
interaction is particularly interesting since genes within the Th2
cytokine locus and the Ifnγ locus are expressed speciﬁcally in
lineages (Th2 and Th1 lymphocytes, respectively) that are both
derived from naïve CD4+ T cells; the interchromosomal interaction
appeared strongest in these cells and was diminished after
differentiation into Th2 or Th1 cells.
A similar picture has also emerged for the function of Polycomb
group (PcG) proteins in gene repression (a comprehensive overview
of PcG function is beyond the scope of this article, but for current
reviews see Simon and Kingston, 2009, and Müller and Verrijzer,
2009). 3C-based studies, along with other approaches, have
suggested that DNA sequences associated with PcG factors coloca-
lize with silenced gene promoters, and that the PcG factors
themselves are responsible for promoting long-range intrachromo-
somal and interchromosomal interactions to form repressive
domains within the nucleus (Cleard et al., 2006; Lanzuolo et al.,
2007; Tiwari et al., 2008). These studies and a host of others suggest
that distal regulatory elements function via colocalization with the
promoters they regulate, resulting in the formation of speciﬁc three-
dimensional conformations within the nucleus that facilitate the
molecular steps required for gene activation (Fig. 1A). Thus,
enhancer function is linked to larger patterns of nuclear organiza-
tion – most notably, the spatial segregation of the genome into
compartments that harbor “open” and “closed” chromatin, respec-
tively – that accompany gene expression patterns genome-wide
(Lieberman-Aiden et al., 2009).
Thus far, however, while factor dependence for such associations
has often been shown, the molecular interactions responsible for
bringing about the observed juxtapositions between enhancers and
promoter remain elusive. Factors required for function of enhancer-
blocking elements [CTCF and, in Drosophila, su(Hw)] have beenobserved to form distinct foci within the nucleus, representing
colocalization of multiple CTCF- and su(Hw)-bound sequences
throughout the genome (Wallace and Felsenfeld, 2007; Gaszner
and Felsenfeld, 2006). Evidence for a similar unifying principle for
enhancer-promoter colocalization has been provided by studies
suggesting that within eukaryotic nuclei, RNA polymerase II also
forms distinct foci, implying the presence of so-called “transcription
factories” (Iborra et al., 1996). Notably, in addition to gene
promoters, many enhancers are associated with RNA polymerase II,
which would suggest that colocalization of enhancers and promoters
involves association of both types of element with the same
transcription factories (Fig. 1B). A study of the α-globin locus that
utilized 3C along with chromatin immunoprecipitation (ChIP) to
reveal RNA polymerase II binding sites demonstrated a perfect
correlation: all sequences found to colocalize by 3C were associated
with RNA polymerase II and vice versa (Vernimmen et al., 2007). In
addition, in studies of the β-globin locus there is an excellent
correlation between conditions under which promoter-LCR interac-
tions are lost (for example, in cells lacking GATA-1 and EKLF) and the
absence of RNA polymerase II at the promoter (Drissen et al., 2004;
Vakoc et al., 2005). This raises an important question: is colocaliza-
tion of enhancers and promoters, as revealed by 3C, an underlying
mechanism of enhancer-promoter communication, or is it simply a
consequence of the association of RNA polymerase II with both types
of regulatory element?
Within the β-globin locus, simultaneous deletion of 3′HS1 and
the −60 HS resulted in no measurable phenotype (Bender et al.,
2006); thus, loss of two of the three CTCF-bound elements known
to comprise the “pre-ACH” had no effect on β-globin gene
expression. In support of this, the absence of CTCF in murine
erythroid progenitors similarly had no effect on β-globin gene
expression or colocalization of other, non-CTCF-bound elements
within the locus as determined by 3C (Splinter et al., 2006), with
the caveat that undifferentiated progenitors do not express high
levels of β-globins normally. Thus, while some studies have shown
that loss of gene expression correlates with loss of nuclear
colocalization as revealed by 3C, other studies have shown that
interactions revealed by 3C are not necessarily functional in gene
regulation.
FISH analysis of erythroid cells has shown that active genes
throughout mouse chromosome 7 colocalize within the nucleus, and
at surprisingly high frequencies (Osborne et al., 2004). For example,
the active β-globin gene appears to colocalize with active genes at
the other end of chromosome 7 in 40–60% of cells. In fact,
combination of 3C with microarray technology – termed “4C” –
has shown that in general, active genes appear to colocalize with
other active genes on the same chromosome, with some interchro-
mosomal interactions as well (Simonis et al., 2006). Conversely,
inactive genes tend to colocalize with other inactive genes on the
same chromosome. Such studies have been interpreted to suggest
an organization within the nucleus in which active gene loci form
self-organized clusters, within which concentrations of activating
factors are thus high enough to reinforce the active state.
Transfection-based studies have suggested that different types of
genes tend to cluster in the same RNA polymerase “factories,”
implying that this self-organizing principle extends beyond active/
inactive to include speciﬁc gene classiﬁcations within the nucleus
(Xu and Cook, 2008) (Fig. 1C).
The question that arises, however, is then to what degree speciﬁc
enhancer-promoter interactions revealed by 3C actually contribute to
gene activation. If the β-globin LCR colocalizes with other active genes
on chromosome 7 nearly as frequently as it does with an active β-
globin gene, then if this colocalization is important for function, the β-
globin LCR should have a regulatory inﬂuence on the other genes as
well. It is not yet known, however, if deletion of the β-globin LCR
affects expression levels of other genes on mouse chromosome 7.
Fig. 2. Potential role of intervening DNA between enhancers and promoters, and factors that associate with it, in enhancer function. An enhancer and a promoter within a gene locus
(top left) are both bound by sequence-speciﬁc factors, which in turn serve to recruit a factor or complex that then associates with chromatin throughout the locus (bottom left). We
depict several potential mechanisms that might then ensue: (1) factors bound between the enhancer and promoter serve to organize the intervening chromatin in order to bring the
two elements together spatially; (2) factors extending from the enhancer to the promoter along the intervening chromatin serve as the primary signal for gene activation, with no
necessary role for enhancer-promoter juxtaposition; (3) factors associating with the intervening chromatin organize the locus to bring both enhancer and promoter to a transcription
factory and accomplish gene activation. Conceivably, enhancer-promoter juxtaposition at transcription factories may be an event secondary to gene activation, as in (2).
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transcription factories, are still largely unknown, and most of the
available evidence consists of correlations, not demonstrations of
function. There is reason for skepticism. For example, the aggregates
of the su(Hw) protein that provided the initial evidence for the
clustering of su(Hw)-bound DNA sequences appear to be unrelated to
the enhancer-blocking function of these sequences (Golovnin et al.,
2008).
Enhancer-blocking and a potential role for intervening DNA in
enhancer function
Alternatively, LCR- or enhancer-promoter colocalization revealed
by 3C or FISH may not reﬂect the major or only mechanism by which
activation occurs. Several observations of enhancer function argue
against a simple “looping” model for interactions with promoters,
starting with the early ﬁnding that sequences and cognate binding
factors that activate promoters over long distances in mammalian
cells fail to do so when imported into the yeast S. cerevisiae (Dorsett,
1999). This has been interpreted as an indication that an activity
required for long-range function is missing in yeast. In addition, even
in mammals the ability of enhancers to activate transcription appears
to be developmentally acquired, coinciding with the onset of
transcriptional repression in a 2-cell embryo in mice (Majumder
and DePamphilis, 1995).
The activity of enhancer-blocking elements suggests not only that
the mechanism by which enhancers and promoters interact is more
complex than colocalization alone, but that the intervening DNA
between such elements is also important. This activity has long been
recognized as a signiﬁcant clue to how enhancer-promoter commu-
nication occurs, although its precise meaning has never been clear.
Such elements do not appear to inactivate either the promoter or the
enhancer, nor do they “trap” the enhancer such that it cannot interact
with another promoter, or the promoter so that it cannot interact with
another enhancer (Dorsett, 1999).
Perhaps the most popular model for the mechanism by which
enhancer-blocking elements work is that they divide genomic DNA
into “topologically distinct” domains across which sequence-speciﬁc
trans-interactions cannot occur (Gaszner and Felsenfeld, 2006). It is
not obvious, however, how two regions of the genome can be kept
“topologically distinct” when the presumed mechanism for enhancer
function involves direct interactions that can occur across different
chromosomes. In addition, at least one process that is known to
require direct interaction between DNA sequences that can be located
far from each other within the genome – site-speciﬁc recombination
by Flp recombinase – is not inhibited by interposing an enhancer-
blocking element between recombinase sites (Dunaway et al., 1997).
Thus, although the best evidence suggests a correlation between gene
activation and enhancer-promoter colocalization within the nucleus,
such colocalization is either established by a process that involves the
intervening DNA, or is accompanied by such a process (Fig. 2). It is
then this process that enhancer-blocking elements disrupt, and is in
turn not present in S. cerevisiae.
Some hints have been presented that suggest a mechanism by
which enhancer-promoter interactions are mediated via intervening
sequences. First, based on the activity of enhancer-blocking ele-
ments, a genetic screen was performed in Drosophila that identiﬁed a
protein termed Chip (with homologues termed Ldb-1 and -2 in
mammals) as a crucial cofactor in the activity of multiple enhancer
elements (Morcillo et al., 1997; Dorsett, 1999). Based on the known
properties of Chip, it was suggested that this protein was responsible
for forming multiple “mini-loops” between an enhancer and a
promoter that effectively shortened the distance between them and
facilitated their interaction. Notably, the other factor that emerged
from the same genetic screen in Drosophila was Nipped-B, which is
required for the loading of cohesins onto chromosomes during Sphase, again implying a function in bridging the gap between
enhancer and promoter by effectively shortening the distance
between them (Dorsett, 2009).
A study of the β-globin locus in mammals has also shown that the
histone methyltransferase MLL2 is associated with chromatin extend-
ing from the LCR to the active gene (Demers et al., 2007). Loss of the
LCR-binding transcription factor NF-E2 resulted in loss of transcrip-
tion and also loss of association of MLL2 throughout the locus. Thus,
the β-globin LCR, while apparently colocalizing with the active gene
promoters, is also required for the association of a histone modifying
enzyme throughout the locus, including regions with which it does
not appear to colocalize. Notably, genomic mapping of Nipped-B
binding across the Drosophila genome similarly revealed large blocks
of sequence that were continuously associated with this factor
(Dorsett, 2009). The data again suggest a role for the intervening
DNA in enhancer function via the generalized association of cofactors.
Summary
The ﬁrst demonstrations of gene activation by sequences located
far from promoters are now nearly 30 years old (Banerji et al., 1981;
Moreau et al., 1981); the ﬁrst demonstration of LCR activity in
transgenes was made more than 20 years ago (Grosveld et al., 1987).
In the time since these discoveries, major advances have beenmade in
our understanding of gene regulation and the underlying processes –
transcription by RNA polymerase II, modulation of chromatin
structure and nuclear organization – accompanied by the develop-
ment of new technologies that have suggested an unexpected breadth
and complexity to the occurrence and activity of distal regulatory
elements, and revealed enhancer-promoter interactions suggestive of
the mechanism by which they function. Despite these advances,
however, it is clear that answers to the most basic questions of
enhancer function are as yet far from complete. Given the demon-
strated importance of distal elements in the function of many gene
loci, and the general importance implied by the potential for as many
as a million enhancers in mammalian genomes, further studies of
their function would appear to be a major requirement for a full
understanding of gene regulation.
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